Articleposted 2024-07-24 18:45:22
Italian HCV eradication screening protocol and genotypes characterization (2022–2023) in Ferrara’s province: a real-world study
Nicolò Landini, Chiara Chiericati, Michela Boni, Loredana Simone, Massimo Trombini, Chiara Zanforlin, Caterina Palmonari
Under Review
at
Articleposted 2024-05-08 14:27:37
Assessing prognosis in HCV-induced early-stage liver cirrhosis: An integrated model based on CX3CR1-associated immune infiltration genes
Haozheng Cai, Jing Zhang, Chuwen Chen, Junyi Shen, Xiaoyun Zhang, Wei Peng, Chuan Li, and 2 more authors
Under Revision
at
Articleposted 2023-01-27 02:49:42
Epistatic interactions promote resistance against direct-acting antivirals targeting the HCV NS3 protein
Hang Zhang, Ahmed Abdul Quadeer, Matthew McKay
Published
at
Articleposted 2023-01-12 13:40:02
Portal venous blood flows determine liver function in patients with decompensated cirrhosis due to HCV infection receiving successful sofosbuvir/velpatasvir therapy
Yoshihito Uchida, Yukinori Imai, Shohei Tsuji, Hayato Uemura, Jun-ichi Kouyama, Kayoko Naiki, Satsuki Ando, and 6 more authors
Posted
at
